In the third installment of “The Pandemic Puzzle: Lessons from COVID-19,” leaders and experts in government, academia, health care and business said the U.S. government must step up to build and coordinate a true, robust public health system.

A Stanford study at a California prison found that although there were more breakthrough COVID-19 infections than before the emergence of the delta variant, vaccinated prison residents had few symptomatic cases.

Pediatrician Lisa Chamberlain will lead a new office that promotes pediatric health equity via research, community engagement and health policy.

In the second installment of “The Pandemic Puzzle: Lessons from COVID-19,” leaders and experts from government, academia, health care and business said the road to health equity begins and ends in the underserved communities.

Stanford School of Medicine’s new health policy department will be a hub for research and education on the causes of and solutions to health inequities.

Newly diagnosed breast or ovarian cancer patients who carry common cancer-associated mutations have similar or better short-term survival rates than those with no mutations, researchers report.

More than two dozen experts discussed how to combat misinformation about COVID-19 and the vaccines at a virtual conference held Aug. 26.

The Stanford School of Medicine and Stanford Graduate School of Business will convene experts in health care, business and government to discuss the global response to the COVID-19 pandemic, lessons for recovery and how to prepare for future health threats.

With the COVID-19 pandemic and the growth of wildfires, California schools need to improve their air quality, according to Stanford pediatrician Lisa Patel. Fortunately, the funds are available.

The Food and Drug Administration has approved a new and expensive medication for Alzheimer’s disease, but it’s not clear it helps. Researcher Kevin Schulman discusses what the government should consider before deciding to cover it.